Immediate Impact
1 by Nobel laureates 50 standout
Citing Papers
Interferon-γ: teammate or opponent in the tumour microenvironment?
2021 Standout
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Works of Figlin Ra being referenced
Adjuvant therapy in renal cell carcinoma: does higher risk for recurrence improve the chance for success?
2017
Recombinant interferon alfa-2a in metastatic renal cell carcinoma: assessment of antitumor activity and anti-interferon antibody formation.
1988
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Figlin Ra | 90 | 101 | 112 | 15 | 247 | |
| Feiteng Lu | 55 | 97 | 108 | 21 | 280 | |
| Songwei Feng | 73 | 80 | 121 | 21 | 251 | |
| Maria Grazia Mameli | 134 | 113 | 118 | 11 | 299 | |
| Troy A. McEachron | 68 | 61 | 105 | 17 | 290 | |
| Xiangshan Yang | 67 | 76 | 132 | 21 | 288 | |
| Víctor Albarrán | 65 | 134 | 62 | 16 | 231 | |
| Adam Diehl | 69 | 215 | 53 | 15 | 290 | |
| Fred J. Kudrik | 42 | 164 | 79 | 12 | 266 | |
| Christian H. Bergsland | 59 | 149 | 124 | 14 | 289 | |
| Sotirios Lakis | 75 | 121 | 73 | 21 | 268 |
All Works
Loading papers...